Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecf631ba60ae8b9030ffa82318ae99ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_819e835ea8581b3bd8eb3d14c8a505e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_981af305a89d8e88bfde78462c1f676e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_982ed62317118e5556954278ca00626e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c70593627fd645c7027062085154babb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B30-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2010-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0491ac828ac3686788e1dd10eae4d10b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f6515025e141646df4038e7c96c3635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea0f953cd8339f064412785d172137f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47e9b8324fe6fe45e0ac3f485967df88 |
publicationDate |
2012-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2012108655-A1 |
titleOfInvention |
Methods of Diagnosing and Treating Carcinomas |
abstract |
Methods of diagnosing a carcinoma include comparing the expression of miRNAs in a sample with a control and determining ratios of expression of miRNAs. Methods of treatment include administering a nucleic acid encoding a miR-375 gene product. Methods of optimizing treatment in a subject include determining expression of an miR21-gene product. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111593127-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113564250-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3717660-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101804671-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11377699-B2 |
priorityDate |
2009-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |